Amgen invests £50m in UK genetics firm Oxford Nanopore

Amgen invests £50m in UK genetics firm Oxford Nanopore

Source: 
Pharmaforum
snippet: 

US firm Amgen has invested in Oxford Nanopore, which has developed handheld gene sequencing technology that uses nanopores in combination with electronics to perform direct, real-time sequencing of DNA and RNA.